- Direction
- Improving
- Own history
- 67th
- Peers
- 70th
- Persistence
- EMERGING
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTORTHOPEDIATRICS CORP's latest supported as-filed period reports revenue of $72.7M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 143.96% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 4.01% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 6.20% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 18.63% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 195.24% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 74.28% · CORE
Level · gp.fundamentals.operating_margin
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 18.6%; Operating margin moved 958 bp higher; Operating income increased 55.2%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 15.4%; Operating margin moved 1168 bp higher; Operating income increased 61.8%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 1.9%; Operating cash flow changed across a sign change.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 17.4%; Capex / revenue moved 10 bp higher.
2 evidence-backed componentsCurrent liabilities changed +36.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
KIDS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001425450-26-000094SEC ↗8-KOct 27, 2026Period Oct 27, 20260001425450-26-000092SEC ↗8-KOct 27, 2026Period Oct 27, 20260001425450-26-000091SEC ↗4Sep 11, 2026Period Sep 10, 20260001193125-26-388667SEC ↗4Sep 11, 2026Period Sep 10, 20260001193125-26-388664SEC ↗4Sep 10, 2026Period Sep 10, 20260001425450-26-000087SEC ↗4Sep 4, 2026Period Sep 2, 20260001193125-26-383761SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 10, 2026Filed Sep 11, 2026 | Squadron Capital LLCReporting owner | Open Market SaleDirect | 302,369 | $21 | $6.4M | Form 4 ↗ |
| Sep 10, 2026Filed Sep 11, 2026 | Pritzker Jennifer N.Reporting owner | Open Market SaleIndirect | 302,369 | $21 | $6.4M | Form 4 ↗ |
| Sep 10, 2026Filed Sep 10, 2026 | Pelizzon David RDirector | Open Market SaleIndirect | 302,369 | $21 | $6.4M | Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Pelizzon David RDirector | Open Market SaleIndirect | 22,500 | $23 | $525,375 | Form 4 ↗ |
| Sep 2, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value -5.81% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 3.39% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 6.08% · OPTIONAL
Current liabilities changed +67.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -38.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -445 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed -61.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +77.6% from the comparable as-filed period.
Operating income changed +55.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-383746| Squadron Capital LLCReporting owner |
| Open Market SaleDirect |
| 22,500 |
| $23 |
| $525,375 |
| Form 4 ↗ |
| Sep 1, 2026Filed Sep 1, 2026 | Pelizzon David RDirector | Open Market SaleIndirect | 10,131 | $23 | $234,026 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 1, 2026 | Squadron Capital LLCReporting owner | Open Market SaleDirect | 10,131 | $23 | $234,026 | Form 4 ↗ |
| Aug 28, 2026Filed Sep 1, 2026 | Pelizzon David RDirector | Open Market SaleIndirect | 326,700 | $23 | $7.5M | Form 4 ↗ |
| Aug 28, 2026Filed Sep 1, 2026 | Squadron Capital LLCReporting owner | Open Market SaleDirect | 326,700 | $23 | $7.5M | Form 4 ↗ |
| Jun 9, 2026Filed Jun 10, 2026 | Pelizzon David RDirector | Grant Or AwardDirect | 11,436 | $0 | $0 | Form 4 ↗ |